ENTRY       D11380                      Drug
NAME        Nirsevimab (USAN);
            Nirsevimab (genetical recombination) (JAN);
            Nirsevimab-alip;
            Beyfortus (TN)
PRODUCT     BEYFORTUS (Sanofi Pasteur)
FORMULA     C6494H10060N1708O2050S46
EXACT_MASS  146244.2605
MOL_WEIGHT  146334.5658
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVMV SCQASGGLLE DYIINWVRQA PGQGPEWMGG IIPVLGTVHY
            GPKFQGRVTI TADESTDTAY MELSSLRSED TAMYYCATET ALVVSETYLP HYFDNWGQGT
            LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA
            PELLGGPSVF LFPPKPKDTL YITREPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP
            REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL
            PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT
            VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS LSAAVGDRVT ITCQASQDIV NYLNWYQQKP GKAPKLLIYV ASNLETGVPS
            RFSGSGSGTD FSLTISSLQP EDVATYYCQQ YDNLPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H153-H209, H229-L214, H235-H'235, H238-H'238, H270-H330, H376-H434, H'22-H'96, H'153-H'209, H'229-L'214, H'270-H'330, H'376-H'434, L23-L88, L'23-L'88, L134-L194, L'134-L'194)
  TYPE      Peptide
REMARK      ATC code: J06BD08
            Product: D11380<US>
EFFICACY    Antiviral
  DISEASE   RSV disease [DS:H00401]
  TYPE      Monoclonal antibody
COMMENT     Prevention of respiratory syncytial virus infection
TARGET      RSV F protein [KO:K19261]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BD Antiviral monoclonal antibodies
                 J06BD08 Nirsevimab
                  D11380  Nirsevimab (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Respiratory Tract Agents, Other
               Immunomodulators
                Nirsevimab
                 D11380  Nirsevimab (USAN)
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               RSV F protein
                D11380  Nirsevimab (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11380
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11380
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11380
DBLINKS     CAS: 1989556-22-0
            PubChem: 384585358
///
